July 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), a novel CD19-directed chimeric antigen receptor (CAR) T cell treatment developed by Bristol Myers Squibb (BMS), has been approved by the US Fo...
cart-therapy
June 2021 : As per our resources, a hospital in China has developed CAR T-Cell therapy for T-cell acute lymphoblastic leukaemia (T-ALL). The expressing protein in this case is CD7. 5 patients have bee...
cart-therapy
July 2021: Refer to the latest drugs in the treatment of cancer. Every year, after examining the trials and other important factors, the USFDA approves drugs, and thus cancer patients can now believe ...
cart-therapy